GET DAILY SIGNALSWhy Is GMR Solutions (GMRS) Stock Up +0.55% Today?
Key Takeaways
- GMRS shares are up 0.55% in Wednesday's session, trading near $11.05 versus a prior close of $10.99.
- The modest gain reflects a tentative stabilization after a sharp post-earnings selloff earlier this week.
- Q3 results beat on the bottom line, but softer full-year revenue guidance pressured the stock in prior sessions.
- Profit growth was driven largely by debt reduction, raising questions about the quality of the earnings.
- Elevated trading volume suggests continued repositioning by investors following the report.
- Traders are watching same-market revenue growth, ambulance transport volumes, and payor mix for signs of underlying momentum.
- For deeper insight into this name, explore Price Targets, Earnings, and Forecast pages.
- Discover which automated strategies are leading the market right now with Trending AI Robots.
Opening Summary
GMR Solutions Inc. (GMRS), the nation's largest emergency medical services provider, is trading modestly higher Wednesday, up about 0.55% to $11.05 from a prior close of $10.99. The company, which went public in May 2026 and operates ground and air-medical fleets including American Medical Response and Air Evac across roughly 1,400 U.S. counties, is attempting to stabilize after a volatile stretch tied to its third-quarter earnings report. The move marks a tentative rebound following a multi-session slide, with buyers stepping in at lower levels after a quarter that beat profit expectations but disappointed on the outlook.
Post-Earnings Stabilization After a Sharp Selloff
The defining driver behind GMRS's recent trading is the aftermath of its Q3 2026 results, released after Monday's close. The company reported non-GAAP earnings per share of $0.64, well above the roughly $0.52 consensus, and revenue of about $1.6 billion, up 5.9% year over year. The initial reaction was positive, with shares gapping higher, but the rally quickly faded as investors focused on the softer details of the report.
Full-year 2026 revenue guidance of $5.90 billion to $6.05 billion came in below analyst expectations of roughly $6.16 billion, and adjusted EBITDA grew only 4.2% in the quarter. Combined with a decelerating pace of same-market revenue growth and essentially flat ambulance transport volumes, the guidance overshadowed the headline earnings beat. Through Tuesday's close, shares had fallen to $10.99, down more than 11% from the $12.44 close recorded on November 6. Wednesday's small gain suggests some investors view the post-earnings decline as overdone given the bottom-line beat and a Wall Street consensus that remains broadly constructive.
Earnings Quality Concerns Linger
A key theme weighing on sentiment is the composition of the profit beat. Net income surged 81.7% year over year to $135.6 million, but much of that improvement was driven by balance-sheet actions — including the repricing of a senior secured term loan, repayment of $200 million of debt, and lower interest expense — rather than acceleration in the core operating business. Adjusted EBITDA rose just 4.2%, and same-market revenue growth slowed to 6.0%. That divergence between the earnings line and the underlying business has prompted investor caution about the sustainability of the profit expansion, even as the company points to higher revenue per transport and disciplined cost management.
Market Context and Trading Activity
Trading activity has been notably heavier around the earnings release. Daily volume jumped to roughly 3.0 million shares on the report day and about 3.2 million shares the following session, compared with roughly 0.8 million to 1.2 million shares in the preceding week, signaling elevated institutional repositioning. Wednesday's stabilization comes as the stock sits near the lower end of its post-IPO range and well below its $15 May offering price, with the recent slide carrying GMRS through the $11.27 and $11.00 levels before buyers emerged. Broader healthcare-services trading has been mixed, and the stock's move has been driven more by company-specific catalysts than by index-level momentum.
What Comes Next for GMRS
Investors will now turn their attention to the company's fourth-quarter performance and any additional color on 2027 expectations, which management said it will provide with its next report. Key metrics to watch include same-market revenue growth, ambulance transport volumes, revenue per transport, and adjusted EBITDA growth, alongside the company's payor mix — with Medicare and Medicaid representing roughly a third of net transport revenue. Risks include elevated leverage, reimbursement pressures, and the possibility that demand growth remains subdued. With analyst coverage broadly at a "Moderate Buy" consensus, the near-term debate centers on whether operating momentum, rather than debt reduction, can drive the next leg of profit growth.
Trending AI Robots
Tickeron's Trending AI Robots page curates the platform's strongest-performing automated trading strategies under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with bots varying by strategy, timeframe, performance metrics, and traded symbols. Only the top performers are featured in this curated section, giving traders a focused way to identify strategies that are currently excelling. Explore Trending AI Robots to see which automated approaches are leading the market today.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GMRS's RSI Indicator recovers from overbought zone
The 10-day RSI Indicator for GMRS moved out of overbought territory on November 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 instances where the indicator moved out of the overbought zone. In 1 of the 1 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 5 of 6 cases where GMRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
GMRS moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GMRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
GMRS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on GMRS as a result. In 3 of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for GMRS just turned positive on October 09, 2026. Looking at past instances where GMRS's MACD turned positive, the stock continued to rise in 2 of 2 cases over the following month. The odds of a continued upward trend are 90%.
The 10-day moving average for GMRS crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +9.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where GMRS advanced for three days, in 14 of 20 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 9 of 14 cases where GMRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.851) is normal, around the industry mean (204.532). P/E Ratio (-6.129) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.502) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. GMRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GMRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement